A treatable traits approach for asthma in a post-COVID era-Reference-Cited by-同舟云学术

A treatable traits approach for asthma in a post-COVID era

Published:2024-06-27 Issue:3 Volume:2 Page:287-300
ISSN:
Container-title:Exploration of Asthma & Allergy
language:
Short-container-title:Explor Asthma Allergy

Author:

Hamada Yuto¹^ORCID,Majellano Eleanor C.²^ORCID,Gibson Peter Gerard³^ORCID

Affiliation:

1. Centre of Excellence in Treatable Traits, College of Health, Medicine and Wellbeing, The University of Newcastle, New Lambton Heights, NSW 2305, Australia; Clinical Research Centre for Allergy and Rheumatology, National Hospital Organization Sagamihara National Hospital, Sagamihara 252-0392, Japan

2. Centre of Excellence in Treatable Traits, College of Health, Medicine and Wellbeing, The University of Newcastle, New Lambton Heights, NSW 2305, Australia; School of Nursing and Midwifery, College of Health, Medicine and Wellbeing, The University of Newcastle, Newcastle, NSW 2305, Australia

3. Centre of Excellence in Treatable Traits, College of Health, Medicine and Wellbeing, The University of Newcastle, New Lambton Heights, NSW 2305, Australia; Department of Respiratory and Sleep Medicine, John Hunter Hospital, New Lambton Heights, NSW 2305, Australia

Abstract

As a novel respiratory viral infection, coronavirus disease 2019 (COVID-19) has influenced asthma in unpredictable ways. In the post-COVID era, there is a need to review asthma care and the new challenges and opportunities that are presented. Long COVID is a new and complex syndrome that has arisen. Treatable traits (TTs) have already been developed to address complex asthma and can be adapted to manage long COVID. Consumers are seeking more information on and answers to what to expect with a dual diagnosis of asthma and COVID-19. People with asthma identify a strong need for research into COVID and asthma. Completion of a national survey (n = 593) resulted in a list of research themes. From these, participants prioritized 10 asthma research themes. Among the top 10 asthma research priorities, the theme of COVID and asthma was ranked as the second priority in the overall rank list. Addressing these issues has the potential to improve global asthma health.

Funder

National Health and Medical Research Council

Publisher

Open Exploration Publishing

Reference91 articles.

1. Ciotti M, Ciccozzi M, Terrinoni A, Jiang WC, Wang CB, Bernardini S. The COVID-19 pandemic. Crit Rev Clin Lab Sci. 2020;57:365–88.

2. Harapan H, Itoh N, Yufika A, Winardi W, Keam S, Te H, et al. Coronavirus disease 2019 (COVID-19): A literature review. J Infect Public Health. 2020;13:667–73.

3. Verhoeven E, Rouadi P, Jaoude EA, Abouzakouk M, Ansotegui I, Al-Ahmad M, et al. Digital tools in allergy and respiratory care. World Allergy Organ J. 2022;15:100661.

4. Wosik J, Fudim M, Cameron B, Gellad ZF, Cho A, Phinney D, et al. Telehealth transformation: COVID-19 and the rise of virtual care. J Am Med Inform Assoc. 2020;27:957–62.

5. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and atopic eczema: ISAAC. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Lancet. 1998;351:1225–32.